The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial
Abbasi BKimiagar MSadeghniiat KShirazi MMHedayati MRashidkhani B
Evidence is still building up
Summary
A double-blind, placebo-controlled RCT giving magnesium 500 mg/day for 8 weeks to 46 elderly adults with primary insomnia. Subjective sleep time and sleep efficiency improved significantly, early morning awakening decreased, and serum melatonin and renin rose while cortisol fell. Because participants were elderly, the results may not generalize to young athletes, and the sample size was small.
Key findings
- 1
Subjective sleep time and sleep efficiency improved significantly
- 2
Early morning awakening decreased significantly
- 3
Serum renin and melatonin increased, cortisol decreased
Related supplements
PR
Supports sleep quality and ease of falling asleep when correcting deficiency (confirmed in elderly)
The links below include affiliate links (PR).
Last checked: 2026-06-23